WVE Q4 2019 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-33.7% YoY

Gross Profit

-$47M-1947.0% margin

Operating Income

-$61M-2522.2% margin

Net Income

-$57M-2365.4% margin

EPS (Diluted)

$-1.65

QoQ Revenue Growth

-18.1%

Cash Flow

Operating Cash Flow

-$61M

Free Cash Flow

-$63M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$284M

Total Liabilities

$213M

Stockholders' Equity

$72M

Cash & Equivalents

$147M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$4M	-33.7%
Gross Profit	-$47M	-$36M	-29.1%
Operating Income	-$61M	-$49M	-23.7%
Net Income	-$57M	-$38M	-49.8%